A randomized controlled study to evaluate the efficacy of tamsulosin monotherapy and it combination with mirabegron on patients with overactive bladder induced by benign prostatic hyperplasia.
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2014
At a glance
- Drugs Mirabegron (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 12 Feb 2013 Planned End Date changed from 23 Aug 2012 to 12 Feb 2013 as reported by University Hospital Medical Information Network - Japan record.
- 15 Feb 2012 New trial record